AzurRx BioPharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AZRX and buy or sell other stocks, ETFs, and their options commission-free!

About AZRX

Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. 

CEO
Jason D. Sawyer
CEOJason D. Sawyer
Employees
2
Employees2
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2014
Founded2014
Employees
2
Employees2

AZRX Key Statistics

Market cap
3.43M
Market cap3.43M
Price-Earnings ratio
-0.22
Price-Earnings ratio-0.22
Dividend yield
—
Dividend yield—
Average volume
119.38K
Average volume119.38K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$2.95
52 Week high$2.95
52 Week low
$0.84
52 Week low$0.84

People also own

Based on the portfolios of people who own AZRX. This list is generated using Robinhood data, and it’s not a recommendation.
Zomedica
Sundial Growers
Castor Maritime
Naked Brand
Tonix Pharmaceuticals
Acasti Pharma
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.